Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2093]

Omics, early detection and novel therapies: Epigenetic studies

Dr Adele Murrell - University of Bath, Bath, UK

Omics, early detection and novel therapies: Epigenetic studies ( Dr Adele Murrell - University of Bath, Bath, UK )

We should use PDL1 and other biomarkers for selecting patients for immune...

Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK

We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK )

We should not use PDL1 and other biomarkers for selecting patients for immune...

Prof Gordon McVie - King's College London, London, UK

We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Prof Gordon McVie - King's College London, London, UK )

Using PDL1 and other biomarkers in patient selection for immunology: Q & A

Dr O'Brien and Prof McVie

Using PDL1 and other biomarkers in patient selection for immunology: Q & A ( Dr O'Brien and Prof McVie )

Imaging and novel PET tracers: State of the art

Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy

Imaging and novel PET tracers: State of the art ( Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy )

Editor's Choice for September 2016

Prof Gordon McVie - Editor in Chief, ecancer

Editor's Choice for September 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )

When is an assay ready for the clinic?

Dr Erasmus Schneider - Wadsworth Center, Albany, USA

When is an assay ready for the clinic? ( Dr Erasmus Schneider - Wadsworth Center, Albany, USA )

IBCD 2016: Integrating assays into clinical trials

Dr Tracy Lively - National Cancer Institute, USA

IBCD 2016: Integrating assays into clinical trials ( Dr Tracy Lively - National Cancer Institute, USA )

Innovative imaging techinques to visualise drug targets

Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands

Innovative imaging techinques to visualise drug targets ( Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands )

Design and value of immunohistochemical assays

Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA

Design and value of immunohistochemical assays ( Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA )

Oncolytic virotherapy in the treatment of melanoma

Dr Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA

Oncolytic virotherapy in the treatment of melanoma ( Dr Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA )

What is the role of surgery in melanoma treatment?

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy

What is the role of surgery in melanoma treatment? ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )

More from ecancer